Prematurity and Severity Are Associated With Toxoplasma gondii Alleles (NCCCTS, 1981–2009)
Author(s) -
Rima McLeod,
Kenneth M. Boyer,
Daniel Lee,
Ernest Mui,
Kristen Wroblewski,
Theodore Karrison,
A. Gwendolyn Noble,
Shawn Withers,
Charles N. Swisher,
Peter Heydemann,
Mari Sautter,
Jane Babiarz,
Peter Rabiah,
Paul Meier,
Michael E. Grigg
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis258
Subject(s) - medicine , serotype , toxoplasmosis , toxoplasma gondii , disease , pediatrics , immunology , antibody
Congenital toxoplasmosis is a severe, life-altering disease in the United States. A recently developed enzyme-linked immunosorbent assay (ELISA) distinguishes Toxoplasma gondii parasite types (II and not exclusively II [NE-II]) by detecting antibodies in human sera that recognize allelic peptide motifs of distinct parasite types.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom